• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Inter-pregnancy weight gains linked to increased risks of stillbirth and infant mortality

byXiaozhou Liu
December 7, 2015
in Chronic Disease, Obstetrics, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this cohort study of Swedish population, women who gained at least 4 body-mass index (BMI) units between pregnancies had higher relative risks of stillbirth and infant mortality.

2. In overweight women with BMI greater than or equal to 25 kg/m2, weight loss before pregnancy was associated with reduced risk of neonatal mortality

Evidence Rating Level: 2 (Good)

Study Rundown: Despite improving access to perinatal care, rates of stillbirth remain tragically high in developed countries. There has been growing evidence linking maternal overweight status to increased stillbirth and infant mortality. However, weight gain between pregnancies is less well understood as a risk factor for stillbirth during subsequent pregnancies. In this cohort study based on Swedish population, researchers investigated whether changes in maternal BMI during early pregnancy from first to second pregnancies was associated with increased risks of stillbirth and infant mortality after the second pregnancy. Risk of stillbirth was found to increase linearly with increased BMI gain. Risk of infant mortality in second pregnancy increased with BMI gain only in women with healthy BMI during their first pregnancies. The investigators also noted that weight loss before pregnancy in overweight women reduced risk of neonatal. The cohort design is an inherent limitation that precludes establishing causal links. However, the statistical power is strong with information on nearly half a million women, which provides strong evidence of association between inter-pregnancy weight gains and subsequent stillbirth and infant mortality. The study results argue for the need of effective fiscal and public health strategies, with the goal of improving the awareness of healthy diets and physical activity in women of child bearing age.

The study was funded by Swedish Research Council for Health, Working Life and Welfare, and Karolinska Institutet.

Click to read the study in The Lancet

RELATED REPORTS

Amycretin significantly improves weight loss in patients with overweight or obese body weight

#VisualAbstract: Once-Weekly Mazdutide Reduced Body Weight in Obese or Overweight Chinese Adults

#VisualAbstract: Tirzepatide Superior to Semaglutide in Obese Adults Without Diabetes

Relevant Reading: Maternal obesity and infant mortality: a meta-analysis

In-Depth [retrospective cohort]: This is a population-based cohort study of Swedish population. The investigators examined records from the Swedish Medical Birth Register for women whose first and second consecutive single births were recorded from January 1, 1992 to December 31, 2012. A total of 587710 women were included in the study, and complete information including early pregnancy BMI and other covariates was available for 456711 women. The primary outcomes included stillbirths (fetal death at 28 completed weeks or later), infant mortality (death during the first year of life in livebirths), neonatal mortality (death within 28 days of life) and postneonatal mortality (infant death after 28 days). For each outcome, relative risks were calculated using binomial regression.

The rate of stillbirth increased with interpregnancy weight gain in a linear fashion. The relative risk (RR) for stillbirth was 1.15 (95% CI, 0.97-1.35) for BMI changes between 1 and 2. RR increased to 1.38 (95% CI, 1.16-1.63) for BMI changes between 2 and 4, and further increased to 1.55 (95% CI, 1.23-1.96) for BMI changes greater than 4 units.

In women with healthy weight during first pregnancy (BMI <25 kg/m2), the risk of infant mortality also increased with weight gain. RR was 1.27 (95% CI 1.01-1.59) for gains between 2 and 4 BMI units, and 1.60 (95% CI 1.16-2.22) for gains greater than 4 BMI units. For overweight women, loss of more than 2 BMI units was associated with reduced neonatal mortality (RR 0.49, 95% CI, 0.27-0.88).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: BMI
Previous Post

Cesarean delivery for term breech not associated with long-term benefit [Classics Series]

Next Post

2 Minute Medicine Physician Press Podcast – December 2015

RelatedReports

Many new pediatric asthma cases attributable to obesity
Cardiology

Amycretin significantly improves weight loss in patients with overweight or obese body weight

August 6, 2025
#VisualAbstract: Once-Weekly Mazdutide Reduced Body Weight in Obese or Overweight Chinese Adults
StudyGraphics

#VisualAbstract: Once-Weekly Mazdutide Reduced Body Weight in Obese or Overweight Chinese Adults

June 16, 2025
#VisualAbstract: Tirzepatide Superior to Semaglutide in Obese Adults Without Diabetes
StudyGraphics

#VisualAbstract: Tirzepatide Superior to Semaglutide in Obese Adults Without Diabetes

May 20, 2025
#VisualAbstract: Switching from ticagrelor to clopidogrel may demonstrate benefit in patients with large body mass index and prior myocardial infarction
StudyGraphics

#VisualAbstract: Switching from ticagrelor to clopidogrel may demonstrate benefit in patients with large body mass index and prior myocardial infarction

March 31, 2025
Next Post

2 Minute Medicine Physician Press Podcast - December 2015

2 Minute Medicine™ - Weekly Rewind December 7, 2015

Delaying intrathecal therapy in leukemia may preclude need for cranial radiotherapy

2 Minute Medicine Rewind December 7, 2015

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Significant body weight reduction with cagrilintide-semaglutide therapy
  • Machine learning models diagnose celiac disease at similar performance levels to pathologists
  • Presymptomatic treatment of spinal muscular atrophy with risdiplam leads to improved functional outcomes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.